Log in to save to my catalogue

A glycan gate controls opening of the SARS-CoV-2 spike protein

A glycan gate controls opening of the SARS-CoV-2 spike protein

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8488004

A glycan gate controls opening of the SARS-CoV-2 spike protein

About this item

Full title

A glycan gate controls opening of the SARS-CoV-2 spike protein

Publisher

London: Nature Publishing Group UK

Journal title

Nature chemistry, 2021-10, Vol.13 (10), p.963-968

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

SARS-CoV-2 infection is controlled by the opening of the spike protein receptor binding domain (RBD), which transitions from a glycan-shielded ‘down’ to an exposed ‘up’ state to bind the human angiotensin-converting enzyme 2 receptor and infect cells. While snapshots of the ‘up’ and ‘down’ states have been obtained by cryo-electron microscopy and c...

Alternative Titles

Full title

A glycan gate controls opening of the SARS-CoV-2 spike protein

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8488004

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8488004

Other Identifiers

ISSN

1755-4330

E-ISSN

1755-4349

DOI

10.1038/s41557-021-00758-3

How to access this item